Patient-reported outcomes before and after treatment of major depressive disorder
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Patient reported outcomes (PROs) of quality of life (QoL), functioning, and depressive symptom severity are important in assessing the burden of illness of major depressive disorder (MDD) and to evaluate the impact of treatment. We sought to provide a detailed analysis of PROs before and after treatment of MDD from the large Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. This analysis examines PROs before and after treatment in the second level of STAR*D. The complete data on QoL, functioning, and depressive symptom severity, were analyzed for each STAR*D level 2 treatment. PROs of QoL, functioning, and depressive symptom severity showed substantial impairments after failing a selective serotonin reuptake inhibitor trial using citalopram (level 1). The seven therapeutic options in level 2 had positive statistically (P values) and clinically (Cohen's standardized differences [Cohen's d]) significant impact on QoL, functioning, depressive symptom severity, and reduction in calculated burden of illness. There were no statistically significant differences between the interventions. However, a substantial proportion of patients still suffered from patient-reported QoL and functioning impairment after treatment, an effect that was more pronounced in nonremitters. PROs are crucial in understanding the impact of MDD and in examining the effects of treatment interventions, both in research and clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.011 · Cited by 5,128
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
The Whoqol Group (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00009-4 · Cited by 3,802
Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007) · Medical Care · doi:10.1097/01.mlr.0000258615.42478.55 · Cited by 3,118 · cited 1×
“The total score is a sum of the highest score on any one of four sleep items (1-4) + item (5) + the highest score on any one appetite/weight item (6-9) + items (10-14) + the highest score on either of the two psychomotor items (15 and 16).”
BackgroundThe Work and Social Adjustment Scale: a simple measure of impairment in functioning
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.461 · Cited by 2,515
Developing the World Health Organization Disability Assessment Schedule 2.0
Üstün, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., Saxena, S., von Korff, M., & Pull, C. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.09.067231 · Cited by 1,851
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033
Medication Augmentation after the Failure of SSRIs for Depression
Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052964 · Cited by 1,002
Research works printed but not linked: 33
- Murray CJ., 1997, Lancet., 349, 1498, 10.1016/S0140-6736(96)07492-2 · DOI · Paper page
- Kessler RC., 2005, Arch Gen Psychiatry., 62, 617, 10.1001/archpsyc.62.6.617 · DOI · Paper page
- Zung WW., 1993, J Fam Pract., 37, 337
- Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI). Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective., 2012, JAMA., 307, 1636, 10.1001/jama.2012.466 · DOI · Paper page
- Aigner M., 2006, Soc Psychiatry Psychiatr Epidemiol., 41, 81, 10.1007/s00127-005-0997-8 · DOI
- Berlim M., 2007, Quality of Life impairment in Schizophrenia, Mood, and Anxiety Disorders. Dordrecht, the Netherlands: Springer.
- Moore M., 2005, Health Qual Life Outcomes., 3, 1, 10.1186/1477-7525-3-1 · DOI
- Peselow ED., 2014, Int Clin Psychopharmacol., 29, 111, 10.1097/YIC.0000000000000015 · DOI
- Rush AJ., 1987, J Clin Psychiatry., 48, 246
- Pyne JM., 1997, Psychiatr Serv., 48, 224, 10.1176/ps.48.2.224 · DOI · Paper page
- Ritsner M., 2007, Quality of Life Impairment in Schizophrenia, Mood, and Anxiety Disorders. Dordrecht, the Netherlands: Springer;, 10.1007/978-1-4020-5779-3 · DOI
- Endicott J., 1993, Psychopharmacol Bull., 29, 321
- Ware JE., 1992, Med Care., 30, 473, 10.1097/00005650-199206000-00002 · DOI · Paper page
- The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties., 1998, Soc Sci Med., 46, 1569, 10.1016/S0277-9536(98)00009-4 · DOI · Paper page
- EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life., 1990, Health Policy., 16, 199, 10.1016/0168-8510(90)90421-9 · DOI · Paper page
- Sheehan DV., 1983, The Anxiety Disease. New York, NY: Charles Scribner & Sons., 151
- Endicott J., 1997, Psychopharmacol Bull., 33, 13
- Rush AJ., 2003, Biol Psychiatry., 54, 585, 10.1016/S0006-3223(03)00786-8 · doi:10.1016/s0006-3223(03)00786-8
- Beck AT., 1996, Manual for the Beck Depression Inventory-ll. San Antonio, TX: Psychological Corporation..
- Zimmerman M., 2008, Compr Psychiatry., 49, 131, 10.1016/j.comppsych.2007.10.006 · DOI · Paper page
- Radloff LS., 1977, Appl Psychol Measures., 1, 385, 10.1177/014662167700100306 · DOI · Paper page
- Spitzer R., 1999, JAMA., 282, 1737, 10.1001/jama.282.18.1737 · DOI · Paper page
- Teresi JA., 2009, Psychol SciQ., 51, 148
- IsHak WW., 2013, Adm Policy Ment Health., 40, 76, 10.1007/s10488-011-0376-6 · DOI · Paper page
- Fava M., 2003, Psychiatr Clin North Am., 26, 457, 10.1016/S0193-953X(02)00107-7 · DOI · Paper page
- Mundt JC., 2002, Br J Psychiatry., 180, 461, 10.1192/bjp.180.5.461 · DOI · Paper page
- IsHak WW., 2013, Qua I Life Res., 22, 585, 10.1007/s11136-012-0187-6 · DOI
- Lavori PW., 2001, Biol Psychiatry., 50, 792, 10.1016/S0006-3223(01)01223-9 · DOI
- Gaynes BN., 2008, Cleve Clin J Med., 75, 57, 10.3949/ccjm.75.1.57 · DOI · Paper page
- Schecter LE., 2005, NeuroRx., 2, 590, 10.1602/neurorx.2.4.590 · DOI · Paper page
- Warden D., 2009, Int J Neuropsychopharmacol., 12, 459, 10.1017/S1461145708009073 · DOI · Paper page
- Warden D., 2009, Depress Anxiety., 26, 622, 10.1002/da.20541 · DOI · Paper page
- Gaynes BN., 2011, Depress Anxiety., 28, 989, 10.1002/da.20898 · DOI
Cited by
Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132
Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study
DiBernardo, A., Lin, X., Zhang, Q., Xiang, J., Lu, L., Jamieson, C., Benson, C., Lee, K., Bodén, R., Brandt, L., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1920-7 · Cited by 66
Christensen, M. C., Fagiolini, A., Florea, I., Loft, H., Cuomo, A., & Goodwin, G. M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.099 · Cited by 52
Emotional blunting in patients with depression. Part I: clinical characteristics
Christensen, M. C., Ren, H., & Fagiolini, A. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00387-1 · Cited by 53
Hershenberg, R., McDonald, W. M., Crowell, A., Riva-Posse, P., Craighead, W. E., Mayberg, H. S., & Dunlop, B. W. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.108 · Cited by 40
“The instruments used in MBC for depression consist either of structured clinician-rated assessments (CRs) or patient-reported outcomes (PROs), which include self-report questionnaires that assess symptom severity, functioning, or quality of life (IsHak et al., 2014).”
Method
Metadata
- Authors
- IsHak, W. W., Mirocha, J., Pi, S., Tobia, G., Becker, B., Peselow, E. D., & Cohen, R. M.
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2014-06-30
- Volume
- 16
- Issue
- 2
- Pages
- 171-183
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- OpenAlex
- W4322700626
- Cited by
- 45
- References
- 17
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patient-reported outcomes before and after treatment of major depressive disorder. https://app.cochat.ai/papers/10.31887/dcns.2014.16.2/rcohen
- The paper
- IsHak, W. W., Mirocha, J., Pi, S., Tobia, G., Becker, B., Peselow, E. D., & Cohen, R. M. (2014). Patient-reported outcomes before and after treatment of major depressive disorder. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2014.16.2/rcohen
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.